Reversal of antipsychotic-induced hyperprolactinemia, weight gain, and dyslipidemia by aripiprazole: A case report

被引:16
|
作者
Lin, Shih-Ku [1 ]
Chen, Chih-Ken
机构
[1] Taipei City Psychiat Ctr, Dept Gen Psychiat, Taipei, Taiwan
[2] Chang Gung Univ, Chang Gung Mem Hosp, Sch Med, Dept Psychiat, Taoyuan, Taiwan
关键词
D O I
10.4088/JCP.v67n0821a
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
引用
收藏
页码:1307 / 1307
页数:1
相关论文
共 50 条
  • [1] Reversal of symptomatic antipsychotic-induced hyperprolactinemia with addition of aripiprazole
    Paraskevi Kotorki
    Parthena Pelka
    Christina Leotsakou
    Aikaterini Kalogeropoulou
    Markella Fiste
    Georgios Vagionis
    Anastasia Roussi
    Periklis Paterakis
    Annals of General Psychiatry, 9 (Suppl 1)
  • [3] Aripiprazole for the Treatment of Antipsychotic-Induced Hyperprolactinemia in an Adolescent Boy
    Curran, Rebecca L.
    Badran, Ismail A.
    Peppers, Virginia
    Pedapati, Ernest V.
    Correll, Christoph U.
    DelBello, Melissa P.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (05) : 490 - 491
  • [4] Antipsychotic-induced weight gain
    Goudie, AJ
    Cooper, GD
    Halford, JCG
    DIABETES OBESITY & METABOLISM, 2005, 7 (05): : 478 - 487
  • [5] Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia
    Weiden, Peter J.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 : 34 - 39
  • [6] Antipsychotic-induced hyperprolactinemia
    Khouadja, S.
    Ben Soussia, R.
    Bouallagui, A.
    Marrag, I.
    Younes, S.
    Nasr, M.
    EUROPEAN PSYCHIATRY, 2017, 41 : S701 - S701
  • [7] Challenges in Managing Antipsychotic-Induced Hyperprolactinemia: A Case Study and Clinical Considerations for Aripiprazole Integration
    Garde Gonzalez, J.
    Herrero Ortega, P.
    Oliva Lozano, A.
    Morillas Romerosa, M. A.
    Soler, M. N. P.
    EUROPEAN PSYCHIATRY, 2024, 67 : S127 - S127
  • [8] Antipsychotic-Induced Hyperprolactinemia
    Bostwick, Jolene R.
    Guthrie, Sally K.
    Ellingrod, Vicki L.
    PHARMACOTHERAPY, 2009, 29 (01): : 64 - 73
  • [9] Potential control of antipsychotic-induced hyperprolactinemia and obesity in children and adolescents by aripiprazole
    Lian, Jiamei
    Huang, Xu-Feng
    Pai, Nagesh
    Deng, Chao
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (06): : 1157 - 1158
  • [10] Pharmacogenetics of antipsychotic-induced weight gain
    Müller, DJ
    Muglia, P
    Fortune, T
    Kennedy, JL
    PHARMACOLOGICAL RESEARCH, 2004, 49 (04) : 309 - 329